defibrotide sodium

defibrotide sodium (DEFITELIO) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: intravenous. Current US regulatory status: approved.

DEFITELIO is a marketed brand name for defibrotide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

defibrotide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.